Artigo · Revista · 2025

Safety, immunogenicity, and relative efficacy of a parenteral trivalent rotavirus subunit vaccine candidate (TV P2-VP8) in healthy Ghanaian, Malawian, and Zambian infants

Tushar Tewari, George Armah, Nigel A. Cunliffe, Caroline Chisenga, Desiree Witte, Vida Kukula e mais 12

Vaccine

• Acesso aberto · Híbrido
• 10% mais citados do mundo
• Internacional · 6 países

Lê-lo10.1016/j.vaccine.2025.128019